Siqi Xu Selected Research

polydatin

1/2016	Polydatin ameliorates injury to the small intestine induced by hemorrhagic shock via SIRT3 activation-mediated mitochondrial protection.
1/2016	Polydatin Protecting Kidneys against Hemorrhagic Shock-Induced Mitochondrial Dysfunction via SIRT1 Activation and p53 Deacetylation.
11/2015	Polydatin Inhibits Mitochondrial Dysfunction in the Renal Tubular Epithelial Cells of a Rat Model of Sepsis-Induced Acute Kidney Injury.
9/2015	Polydatin: a new therapeutic agent against multiorgan dysfunction.
1/2015	Polydatin Alleviates Small Intestine Injury during Hemorrhagic Shock as a SIRT1 Activator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siqi Xu Research Topics

Disease

4	Inflammation (Inflammations) 12/2021 - 10/2018
4	Neoplasms (Cancer) 12/2021 - 01/2018
4	Sepsis (Septicemia) 01/2021 - 09/2015
4	Hemorrhagic Shock 01/2019 - 01/2015
3	Bradycardia 06/2022 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 02/2022 - 01/2018
3	Postoperative Nausea and Vomiting (PONV) 01/2021 - 01/2021
3	Acute Kidney Injury (Acute Renal Failure) 01/2016 - 11/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 09/2015
3	Shock 11/2015 - 01/2015
2	Nausea 06/2022 - 01/2021
2	Bites and Stings (Sting) 04/2022 - 11/2019
2	Postoperative Pain 01/2021 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 06/2015
2	Rheumatoid Arthritis 01/2019 - 03/2018
2	Hemorrhage 01/2019 - 09/2015
1	Pain (Aches) 06/2022
1	Vomiting 06/2022
1	Hypoxia (Hypoxemia) 06/2022
1	Hypotension (Low Blood Pressure) 06/2022
1	Nephritis 02/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2022
1	Uremia 01/2021
1	Lung Injury 01/2021
1	Endotoxemia 01/2021
1	Secondary Hyperparathyroidism 01/2021
1	Cough 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2018
1	Body Weight (Weight, Body) 01/2018
1	Neuralgia (Stump Neuralgia) 01/2018
1	Experimental Diabetes Mellitus 01/2018
1	Dementia (Dementias) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2015
1	Multiple Organ Failure (MODS) 09/2015
1	Lymphatic Metastasis 02/2015

Drug/Important Bio-Agent (IBA)

5	Sirtuin 1IBA 01/2019 - 01/2015
5	polydatinIBA 01/2016 - 01/2015
4	Lidocaine (Xylocaine)FDA LinkGeneric 06/2022 - 01/2019
4	Dexmedetomidine FDA Link 06/2022 - 01/2019
3	Small Interfering RNA (siRNA)IBA 04/2022 - 11/2019
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 02/2015
3	Pharmaceutical PreparationsIBA 01/2018 - 09/2015
2	Remifentanil (Ultiva)FDA Link 06/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 04/2022 - 12/2021
2	InterferonsIBA 04/2022 - 11/2019
2	Sirtuin 3IBA 01/2021 - 01/2016
2	SirtuinsIBA 01/2021 - 01/2016
2	AndrogensIBA 01/2020 - 06/2015
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 06/2015
2	CytokinesIBA 11/2019 - 09/2015
2	Saline SolutionIBA 01/2019 - 09/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2022
1	pristane (pristan)IBA 02/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	Leucine (L-Leucine)FDA Link 12/2021
1	Long Noncoding RNAIBA 12/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021
1	nitidineIBA 12/2021
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2021
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2021
1	MelatoninIBA 01/2021
1	VA 061 (VA061)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	UbiquitinIBA 01/2019
1	Antimalarials (Antimalarial Agents)IBA 10/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2018
1	piperlongumineIBA 03/2018
1	ErbB Receptors (EGF Receptor)IBA 02/2018
1	Carcinoembryonic AntigenIBA 02/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	ResveratrolIBA 01/2016
1	PolyphenolsIBA 11/2015
1	Caspase 3 (Caspase-3)IBA 09/2015
1	Advanced Oxidation Protein Products (AOPP)IBA 09/2015
1	Therapeutic UsesIBA 09/2015
1	LigandsIBA 06/2015
1	Hormones (Hormone)IBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2015
1	ChromatinIBA 06/2015
1	Messenger RNA (mRNA)IBA 02/2015

Therapy/Procedure

3	Ligation 01/2021 - 09/2015
3	Punctures 01/2021 - 09/2015
2	Therapeutics 04/2022 - 02/2018
2	Hysterectomy 01/2021 - 01/2021
1	Parathyroidectomy 01/2021
1	Analgesia 01/2021
1	Cervical Plexus Block 01/2021
1	Anesthesia 01/2021
1	General Anesthesia 01/2021
1	Intravenous Infusions 01/2019
1	Castration 06/2015